519 POSTER A phase 2, single-arm study of volociximab (an anti-a5b1 integrin antibody) monotherapy in patients with platinum-resistant advanced epithelial ovarian cancer or primary peritoneal cancer

Autor:	M. Barve, C.M. Matthews, Ernst Lengyel, K. Gilder, S. Weymer, R.T. Penson, K.M. Bell-McGuinn, L. Gilbert, Steffan Ho, R.J. Schilder
Rok vydání:	2008
Předmět:	Oncology Cancer Research medicine.medical_specialty biology Peritoneal cancer business.industry Volociximab Integrin Internal medicine biology.protein Medicine In patient Epithelial ovarian cancer Antibody business Platinum resistant medicine.drug Single Arm Study
Zdroj:	European Journal of Cancer Supplements. 6:164-165
ISSN:	1359-6349
DOI:	10.1016/s1359-6349(08)72453-4
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::6ff21f60a0e73b25c53bd9a65fd6fd36 https://doi.org/10.1016/s1359-6349(08)72453-4 Zobrazit plný text záznamu Full Text from ScienceDirect